SCHEMBL6943564

SCHEMBL6943564

C#Cc1cccc2cc(-c3nc(C4CCC(C(=O)O)CC4)n4ccnc(N)c34)[nH]c12

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.81
MTOR P42345 2/20 0.81
PIK3CG P48736 2/20 0.81
PRKDC P78527 2/20 0.81
RICTOR Q6R327 2/20 0.81
RPTOR Q8N122 2/20 0.81
MAPKAP1 Q9BPZ7 2/20 0.81
MLST8 Q9BVC4 2/20 0.81
PIK3CB P42338 1/20 0.81
RIPK2 O43353 1/20 0.57
RET P07949 1/20 0.57
NQO2 P16083 1/20 0.57
CSNK2A2 P19784 1/20 0.57
FECH P22830 1/20 0.57
ACVR1B P36896 1/20 0.57
TGFBR1 P36897 1/20 0.57
MAPK10 P53779 1/20 0.57
MAP2K5 Q13163 1/20 0.57
BMPR2 Q13873 1/20 0.57
PIP4K2C Q8TBX8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8064575 1.00 PIK3CA (0.81) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL6940216 0.93 PIK3CA (0.79) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL8072602 0.91 PIK3CA (0.67) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL13962745 0.90 PIK3CA (0.85) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL8076972 0.90 PIK3CA (1.00) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL6944351 0.90 PIK3CA (1.00) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL6942690 0.90 PIK3CA (0.84) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL13962729 0.90 PIK3CA (0.84) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL31060723 0.90 PIK3CA (1.00) PIK3CAMTORPIK3CGPRKDCRICTOR
SCHEMBL6941915 0.90 PIK3CA (1.00) PIK3CAMTORPIK3CGPRKDCRICTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190496-A1 FUSED BICYCLIC mTOR INHIBITORS OSI PHARMACEUTICALS, INC. 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190496-A1 FUSED BICYCLIC mTOR INHIBITORS MTOR, RICTOR, MAPKAP1 PIK3CA 25/4885MTOR 1/4885PIK3CG 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.